• Jirayos Chintanadilok
  • Bradley S. Bender
Part of the Infectious Disease book series (ID)


Sepsis is the clinical syndrome denoting systemic inflammatory response to an infection. There is some confusion over the use of the terms “bacteremia” and “septicemia.” Most studies in the United States used the term bacteremia to denote a positive blood culture with evidence of infection. Septicemia was used to denote a state of microbial invasion from a portal of entry into the bloodstream that causes signs of illness. Sepsis syndrome was initially described by Bone et al. to identify a population of patients at risk for adult respiratory distress syndrome (ARDS) and death (1).


Septic Shock Severe Sepsis Systemic Inflammatory Response Syndrome Positive Blood Culture Multiple Organ Dysfunction Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bone, R.C., Fisher, C.J., Clemmer, T.P., et al. (1989) Sepsis syndrome: a valid clinical entity. Crit. Care Med. 17, 389–393.PubMedCrossRefGoogle Scholar
  2. 2.
    Bone, R.C., Balk, R.A., Cerra, F.B., et al. (1992) American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: definitions for sepsis and multiple-organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101, 1644–1655.PubMedCrossRefGoogle Scholar
  3. 3.
    Rangel-Frausto, M.S., Pittet, D., Costigan, M., et al. (1996) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273, 117–123.CrossRefGoogle Scholar
  4. 4.
    Bernard, R.B. (1997) Issues in the design of clinical trials for sepsis. Cytokines and pulmonary infection. Part 2; the role of cytokines in systemic and pulmonary medicine. ATS Continuing Education Monograph Series (Pratter, M.R., ed. ), American Thoracic Society New York, pp 1–6.Google Scholar
  5. 5.
    Centers for Disease Control and Prevention. Increase in national hospital discharge survey rates for septicemia, United States 1979–1987. (1990) M.M.W.R. 39, 31–34.Google Scholar
  6. 6.
    CDC National Center for Health Statistics. Mortality patterns-United States, 1990. (1993) Monthly Vital Stat. Rep. 41, 45.Google Scholar
  7. 7.
    Sands, K.E., Bates, D.W., Lanken, P.N,. et al. (1997) Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 278, 234–240.PubMedCrossRefGoogle Scholar
  8. 8.
    Brun-Buisson, C., Doyon, F., Carlet, J., et al. (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274, 968–974.Google Scholar
  9. 9.
    Knaus, W.A., Harrell, F.E., Fisher, C.J., et al. (1993) The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA 270, 1233–1241.PubMedCrossRefGoogle Scholar
  10. 10.
    Geerdes, H.F., Ziegler, D., Lode H., et al. (1992) Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989. Clin. Infect. Dis. 15, 991–1002.PubMedCrossRefGoogle Scholar
  11. 11.
    Niederman, M.S. and Fein, A.M. (1990) Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: a common clinical sequence. Clin. Chest Med. 11, 663–665.Google Scholar
  12. 12.
    Friedman, G., Silva, E., and Vincent, J.L. (1998) Has the mortality of septic shock changed with time? Crit. Care Med. 26, 2078–2086.PubMedCrossRefGoogle Scholar
  13. 13.
    Pinner, R.W., Tutsch, S.M., Simonsen, L., et al. (1996) Trends in infectious diseases mortality in the United States JAMA 275, 189–193.PubMedCrossRefGoogle Scholar
  14. 14.
    Winn, T., Tayback, M., and Israel, E. (1991) Mortality due to septicemia in the elderly: factors accounting for a rapid rise. Maryland Med. J. 40, 803–807.Google Scholar
  15. 15.
    McCue, J.D. (1987) Gram-negative bacillary bacteremia in the elderly: incidence, ecology, etiology and mortality. J. Am. Geriatr. Soc. 35, 213–218.PubMedGoogle Scholar
  16. 16.
    Sonnenblick, M., Carmon, M., Rudenski, B., et al. (1990) Septicemia in the elderly: incidence, etiology and prognostic factors. Isr. J. Med. Sci. 26, 195–199.PubMedGoogle Scholar
  17. 17.
    Parker, M.M. and Parrillo, J.E. (1983) Septic shock. Hemodynamics and pathogenesis. JAMA 250, 3324–3327.PubMedCrossRefGoogle Scholar
  18. 18.
    Bone, R.C. (1991) The pathogenesis of sepsis. Ann. Intern. Med. 115, 457–469.PubMedCrossRefGoogle Scholar
  19. 19.
    Boldt, J., Muller, M., Heesen, M., et al. (1997) Does age influence circulating adhesion molecules in the critically ill? Crit. Care Med. 25, 95–100.PubMedCrossRefGoogle Scholar
  20. 20.
    Rink, L., Cakman, I., and Kirchner, H. (1998) Altered cytokine production in the elderly. Mech. Ageing Dey. 102(2–3), 199–209.CrossRefGoogle Scholar
  21. 21.
    Chassagne, P., Perol, M.B., Trivalle, C., et al. (1996) Is presentation of bacteremia in the elderly the same as in younger patients. Am. J. Med. 100, 65–70.PubMedCrossRefGoogle Scholar
  22. 22.
    Van Dijk, J.M., Rosin, A.J., and Rudenski, B. (1982) in the elderly. Practitioner 226, 1439–1443.Google Scholar
  23. 23.
    Windsor, A.C.M. (1983) Bacteraemia in a geriatric unit. Gerontology 29, 125–130.PubMedCrossRefGoogle Scholar
  24. 24.
    Finkelstein, M.S., Petkun, W.M., Freedman, M.L., et al. (1983) Pneumococcal bacteremia in adults: Age-dependent differences in presentation and in outcome. J. Am. Geriatr. Soc. 31, 19–27.PubMedGoogle Scholar
  25. 25.
    Gleckman, R. and Hibert, D. (1982) Afebrile bacteremia. A phenomenon in geriatric patients. JAMA 248, 1478–1481.PubMedCrossRefGoogle Scholar
  26. 26.
    Miller, D., Yoshikawa, T., Castle, S.C., et al. (1991) Effect of age on fever response to recombinant tumor necrosis factor alpha in a murine model. J. Gerontol. 46, M176–179.PubMedCrossRefGoogle Scholar
  27. 27.
    Norman, D.C. and Yoshikawa, T.T. (1983) Intraabdominal infections in the elderly. J. Am. Geriatr. Soc. 31, 677–684.PubMedGoogle Scholar
  28. 28.
    Weinstein, M.P., Towns, M.L., Quartey, S.M., et al. (1997) The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24, 584–602.PubMedGoogle Scholar
  29. 29.
    Gransden, W.R. (1994) Septicemia in the newborn and elderly. J. Antimicrob. Chemother. 34(Suppl. A), 101–119.PubMedCrossRefGoogle Scholar
  30. 30.
    Muder, R.R., Brennen, C., Wagener, M.M., et al (1992) Bacteremia in a long-term-care facility: five-year prospective study of 163 consecutive episodes. Clin. Infect. Dis. 14, 647–654.PubMedCrossRefGoogle Scholar
  31. 31.
    Kreger, B.E., Craven, D.E., Carling, P.C., et al. (1980) Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am. J. Med. 68, 332–343.PubMedCrossRefGoogle Scholar
  32. 32.
    Howell, T.H. (1948) Normal temperatures in old age. Lancet 1, 517–520.PubMedCrossRefGoogle Scholar
  33. 33.
    Castle, S.C., Norman, D.C., Yeh, M., et al. (1991) Fever response in elderly nursing home residents. Are the older truly colder? J. Am. Geriatr. Soc. 39, 853–857.PubMedGoogle Scholar
  34. 34.
    Bender, B. (1992) Sepsis. Clin. Geriatr. Med. 8, 913–924.PubMedGoogle Scholar
  35. 35.
    Iberti, T.J., Bone, R.C., Fein, A., et al. (1993) Are the criteria used to determine sepsis applicable for patients >75 years of age? Crit. Care Med. 21, S130.CrossRefGoogle Scholar
  36. 36.
    Esposito, A.L.M., Gleckman, R.A., Cram, S. et al. (1980) Community-acquired bacteremia in the elderly: analysis of one hundred consecutive episodes. J. Am. Geriatr. Soc. 28, 315–319.PubMedGoogle Scholar
  37. 37.
    Centers for Disease Control and Prevention. (1990) Increase in national hospital discharge survey rates for septicemia: United States, 1979–1987. (1990) M.M.W.R. 39, 31–34.Google Scholar
  38. 38.
    Leibovici, L., Pitlik, S.D., Konisberger, H., et al. (1993) Bloodstream infections in patients older than eighty years. Age Ageing 22, 431–442.PubMedCrossRefGoogle Scholar
  39. 39.
    Setia, U., Serventi, I., and Lorenz, P. (1984) Bacteremia in a long-term care facility. Arch. Intern. Med. 144, 1633–1635.PubMedCrossRefGoogle Scholar
  40. 40.
    Meyers, B.R., Sherman, E., Mendelson, M.H., et al. (1989) Bloodstream infections in the elderly. Am. J. Med. 86, 379–386.PubMedCrossRefGoogle Scholar
  41. 41.
    Madden, J.W., Croker, J.R., and Beynon, C.P.J. (1981) Septicemia in the elderly. Postgrad. Med. J. 57, 502–509.PubMedCrossRefGoogle Scholar
  42. 42.
    Rudman, D., Hontanosas, A., Cohen, Z., et al. (1988) Clinical correlates of bacteremia in a Veterans Administration extended care facility. J. Am. Geriatr. Soc. 36, 726–732.PubMedGoogle Scholar
  43. 43.
    Saviteer, S.M., Samsa, G.P., and Rutala, W.A. (1998) Nosocomial infections in the elderly. Increased risk per hospital day. Am. J. Med. 84, 661–666.CrossRefGoogle Scholar
  44. 44.
    Whitelaw, D.A., Rayner, B.L., and Willcox, P.A. (1992) Community-acquired bacteremia in the elderly: A prospective study of 121 cases. J. Am. Geriatr. Soc. 40, 996–1000.PubMedGoogle Scholar
  45. 45.
    Arbo, M.D.J. and Snydman, D.R. (1994) Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch. Intern. Med. 154, 2641–2644.PubMedCrossRefGoogle Scholar
  46. 46.
    Levy, M., Dremer, F., and Brion, N. (1998) Community-acquired pneumonia: importance of initial noninvasive bacteriologic investigations. Chest 92, 43–48.Google Scholar
  47. 47.
    Caldwell, A., Glauser, F.L., Smith, W.R., et al. (1975) The effects of dehydration on the radiologic and pathologic appearance of experimental canine segmental pneumonia. Am. Rev. Respir. Dis. 112, 651–656.PubMedGoogle Scholar
  48. 48.
    Hall, F.M., Simon, B. (1987) Occult pneumonia associated with dehydration: myth or reality. Am. J. Roentgenol. 148, 853–854.CrossRefGoogle Scholar
  49. 49.
    Mueller, P.R. and Simeonne, J.F. (1983) Intraabdominal abcesses diagnosis by sonography and computed tomography. Radiol. Clin. North Am. 21, 425–448.PubMedGoogle Scholar
  50. 50.
    Van Dissel, J.T., van Langevelde, P., Westendorp, R.G., et al. (1998) Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 28, 950–953.CrossRefGoogle Scholar
  51. 51.
    Cunha, B.A. (1992) Sepsis and its mimics. Intern. Med. 13, 48–52.CrossRefGoogle Scholar
  52. 52.
    Lundberg, J.S., Perl, T.M., Wiblin, T., et al. (1998) Septic shock: An analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit. Care Med. 26, 1020–1024.PubMedCrossRefGoogle Scholar
  53. 53.
    Diep, D., Tran, A., Johan, B., et al. (1990) Age, chronic disease, sepsis, organ system failure, and mortality in a medical intensive care unit. Crit. Care Med. 18, 474–479.CrossRefGoogle Scholar
  54. 54.
    Deulofeu, F., Cervello., B, Capell, S., et al. (1998) Predictors of mortality in patients with bacteremia: The importance of functional status. J. Am. Geriatr. Soc. 46, 14–18.PubMedGoogle Scholar
  55. 55.
    Leibovici, L., Paul, M., Poznanski, O., et al. (1997) Monotherapy versus beta-lactam aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study. Antimicrob. Agents Chemother. 41, 1127–1138.PubMedGoogle Scholar
  56. 56.
    Kollef, M.H., Sherman, G., Ward, S., et al. (1999) Inadequate antimicrobial treatment of infections:A risk factor for hospital mortality among critically ill patients. Chest 115, 462–474.PubMedCrossRefGoogle Scholar
  57. 57.
    Cunha, BA. (1995) Antibiotic treatment of sepsis. Med. Clin. North Am. 79, 551–558.PubMedGoogle Scholar
  58. 58.
    Ognibene, F.P. (1996) Hemodynamic support during sepsis. Clin. Chest Med. 17, 279–287.PubMedCrossRefGoogle Scholar
  59. 59.
    Connors, A.F. Jr, Speroff, T., Dawson, N.V., et al (1998) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 18, 889–897.Google Scholar
  60. 60.
    Parker, M.M. and Peruzzi, W. (1997) Pulmonary artery catheters in sepsis/septic shock. New Horiz. 5, 228–232.PubMedGoogle Scholar
  61. 61.
    Alia, I., Esteban, A., Gordo, F., et al. (1999) A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock. Chest 115, 453–461.PubMedCrossRefGoogle Scholar
  62. 62.
    Maynard, N.D., Bihari, D.J., Dalton, R.N., et al. (1995) Increasing splanchnic blood flow in the critically ill. Chest 108, 1648–1654.PubMedCrossRefGoogle Scholar
  63. 63.
    Meadows, D., Edwards, J.D., Wilkins, R.G., et al. (1998) Reversal of intractable septic shock with norepinephrine therapy. Crit. Care Med. 16, 663–666.CrossRefGoogle Scholar
  64. 64.
    Vincent, J.L., Roman, A., and Kahn, R.J. (1990) Dobutamine administration in septic shock: addition to a standard protocol. Crit. Care Med. 18, 689–693.PubMedCrossRefGoogle Scholar
  65. 65.
    Rudis, M.I., Basha, M.A., and Zarowitz, B.J. (1996) Is it time to reposition vasopressors and inotropes in sepsis? Cuit. Care Med. 24, 525–537.CrossRefGoogle Scholar
  66. 66.
    Hamel, M.B., Teno, J.M., Goldman, L., et al. (1999) Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risks of treatment. Ann. Intern. Med. 130, 116–125.PubMedCrossRefGoogle Scholar
  67. 67.
    Marik, P.E. and Sibbald, W.J. (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269, 3024–3029.PubMedCrossRefGoogle Scholar
  68. 68.
    Mullin, T.J. and Kirkpatrick, J.R. (1981) The effect of nutritional support on immune competency in patients suffering form trauma, sepsis, or malignant disease. Surgery 90, 610–615.PubMedGoogle Scholar
  69. 69.
    Navab, F., Steingrub, J. (1995) Stress ulcer: is routine prophylaxis necessary? Am. J. Gastroenterol. 90, 708–712. -Google Scholar
  70. 70.
    Cook, D., Guyatt, G., and Marshall, J. (1998) A comparison between sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials. N. Engl. J. Med. 398, 791–807.CrossRefGoogle Scholar
  71. 71.
    Prod’hom, G., Leuenberger, P., Koerfer, J., et al. (1997) Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann. Intern. Med. 120, 653–662.CrossRefGoogle Scholar
  72. 72.
    Centers for Disease Control and Prevention. (1997) Guideline for prevention of nosocomial pneumonia. M.M.W.R. 46(RR-1), 1–79.Google Scholar
  73. 73.
    Walsh, C.J., Sugerman, H.J., Mullen, P.G., et al. (1992) Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine Gram-negative sepsis. Arch. Surg. 127, 138–144.PubMedCrossRefGoogle Scholar
  74. 74.
    Fisher, C.J. Jr., Opal, S.M., Lowry, S.F, et al. (1994) Role of IL-1 and the therapeutic potential of IL-1 receptor antagonist in sepsis. Circ. Shock 44, 1–8.PubMedGoogle Scholar
  75. 75.
    Abraham, E., Wunderink, R., Silverman, H., et al. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial. JAMA 273, 934–941.PubMedCrossRefGoogle Scholar
  76. 76.
    Cohen, J. and Carlet, J. (1996) INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. Crit. Care Med. 24, 1431–1440.PubMedCrossRefGoogle Scholar
  77. 77.
    Abraham, E., Anzueto, A., Gutierrez, G., et al. (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 28, 929–933.Google Scholar
  78. 78.
    Greenman, R.L., Schein, R.M.H, and Martin, M.A. (1991) A controlled clinical trial of-E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. JAMA 266, 1097–1102.PubMedCrossRefGoogle Scholar
  79. 79.
    Bone, R.C., Balk, R.A., and Fein, A.M. (1995) A second randomized large controlled clinical study of E 5, a monoclonal antibody to endotoxin, multicenter, randomized, controlled trial. Crit. Care Med. 23, 994–1006.Google Scholar
  80. 80.
    Lefering, R. and Neugebauer, E.A.M. (1995) Steroid controversy in sepsis and septic shock: a meta-analysis. Crit. Care Med. 23, 1294–1303.PubMedCrossRefGoogle Scholar
  81. 81.
    Haupt, M.T., Jastremski, M.S., Clemmer, T.P., et al. (1991) Effects of ibuprofen in patients with severe sepsis: a randomized double-blind, multicenter study. Crit. Care Med. 19, 1339–1347PubMedCrossRefGoogle Scholar
  82. 82.
    King, D.W., Pushparaj, N., and O’Toole, K. (1992) Morbidity and mortality in the aged. Hosp. Pract. 17(2), 97–109.Google Scholar
  83. 83.
    Bolton, C.F., Young, G.B., and Zochodne, D.W. (1993) The neurological complications of sepsis. Ann. Neurol. 33, 94–100.PubMedCrossRefGoogle Scholar
  84. 84.
    Schlag, G., Krosl, P., and Redl, H. (1988) Cardiopulmonary response of the elderly to traumatic and septic shock. Prog. Clin. Biol. Res. 264, 233–242.Google Scholar
  85. 85.
    Chan, E.D. and Welsh, C.H. (1998) Geriatric respiratory medicine. Chest 114, 1704–1733.PubMedCrossRefGoogle Scholar
  86. 86.
    Dematte, J.E., Barnard, M.L., and Sznajder, J.I. (1997) Acute respiratory failure in sepsis, in Sepsis and Multiorgan Failure ( Fein, A.M., ed.), Williams and Wilkins, MD, pp. 155–167.Google Scholar
  87. 87.
    Hussain, S.N. (1998) Respiratory muscle dysfunction in sepsis. Mol. Cell Biochem. 179, 125–134.PubMedCrossRefGoogle Scholar
  88. 88.
    Xu, D., Lu, Q., Guillory, D., et al. (1993) Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J. Trauma 34, 676–683.PubMedCrossRefGoogle Scholar
  89. 89.
    Van Lanschot, J.J.B., Mealy, K., and Wilmore, D.W. (1990) The effects of tumor necrosis factor on intestinal structure and metabolism. Ann. Surg. 212, 663–670.PubMedCrossRefGoogle Scholar
  90. 90.
    Doig, C.J., Sutherland, L.R., Snadham, J.D., et al. (1998) Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am. J. Respir. Crit. Care Med. 158, 444.PubMedCrossRefGoogle Scholar
  91. 91.
    Matuschak, G.M. (1997) Liver dysfunction in sepsis, in Sepsis and Multiorgan Failure ( Fein, A.M., ed.), Williams and Wilkins, MD, pp. 168–180.Google Scholar
  92. 92.
    Neveu, H., Kleinknecht D., Brivet F., et al. (1996) Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicenter study. The French study group on acute renal failure. Nephrol. Dial. Transplant 11, 293–299.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Jirayos Chintanadilok
  • Bradley S. Bender

There are no affiliations available

Personalised recommendations